Clinical benefit of cancer drugs approved in Switzerland 2010–2019

BACKGROUND: It is unknown to what extent cancer drugs approved in Switzerland by the Swissmedic fulfil criteria of clinical benefit according to the European Society of Medical Oncology Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS), the American Society of Clinical Oncology Value Frame...

Descripción completa

Detalles Bibliográficos
Autores principales: Adam, Roman, Tibau, Ariadna, Molto Valiente, Consolación, Šeruga, Boštjan, Ocaña, Alberto, Amir, Eitan, Templeton, Arnoud J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9187080/
https://www.ncbi.nlm.nih.gov/pubmed/35687539
http://dx.doi.org/10.1371/journal.pone.0268545

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9187080/
https://www.ncbi.nlm.nih.gov/pubmed/35687539
http://dx.doi.org/10.1371/journal.pone.0268545

Ejemplares similares